FCEM2-0434
You admit a 65-year-old woman to the clinical decision unit (CDU) following a fall at her assisted living facility. You can see from her notes that she has mild-to-moderate Alzheimer’s disease. While writing up her drug chart, you note that there are some medications you are not familiar with.
Which ONE of the following drugs is NOT recommended by NICE to improve cognition in patients suffering from Alzheimer’s disease?